Sugammadex generic availability?

Sugammadex – is there a generic version?

Yes – sugammadex itself is the generic drug name, and several manufacturers now produce it under that name. While the brand‐named product (often just called “Sugammadex”) has been on the market since the mid‑2010s, generic versions have become available in a number of regions in the past few years.

What does the generic offer?

• Same active ingredient and dosage – 2 mg/kg for moderate reversal, 4 mg/kg for deep block.
• Same indication – reversal of rocuronium or vecuronium‑induced neuromuscular blockade in adults and pediatric patients (within approved weight limits).
• Identical safety profile – adverse events, drug interactions, and monitoring are the same as the branded drug.
• Cost – generics are typically 20–40 % cheaper than the branded product, though the absolute cost is still high (often $300–$600 per vial in the U.S.).

Why use the generic?

1. Cost savings – Even a modest reduction in drug cost can add up quickly in high‑volume surgical centers.
2. Availability – In some markets, the branded product may experience supply constraints; a generic can fill the gap.
3. Clinical equivalence – Numerous pharmacokinetic and pharmacodynamic studies confirm that the generic is bioequivalent to the brand.

Things to keep in mind

• Packaging – Generic vials are typically identical in appearance to the branded product, but always verify the lot number, expiry, and sterility seal.
• Reimbursement – Check your local formulary or insurance coverage; some payers still prefer the branded drug for specific indications or patient populations.
• Switching – If you’re switching a patient from brand to generic, no additional monitoring is required, but keep a record of the switch in the electronic chart.

Bottom line: Sugammad